Title : Equivalent benefit of rapamycin and a potent mTOR ATP-competitive inhibitor, MLN0128 (INK128), in a mouse model of tuberous sclerosis.

Pub. Date : 2013 May

PMID : 23386687






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Rapamycin and related drugs have been shown to have clinical benefit for these tumors in patients with TSC and those with sporadic forms of TSC-related neoplasms. Sirolimus TSC complex subunit 1 Mus musculus
2 Rapamycin and related drugs have been shown to have clinical benefit for these tumors in patients with TSC and those with sporadic forms of TSC-related neoplasms. Sirolimus TSC complex subunit 1 Mus musculus